Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inhibikase Therapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -19.0-17.9-18.1-18.8-18.8-16.8-14.8-11.0
Depreciation and amortization   [+]0.20.00.00.0    
Stock-based compensation  0.20.30.3-0.70.30.10.01.3
Change in working capital   [+]-2.6-2.50.23.63.21.8-0.2-2.5
Other operating activities  1.60.80.2-2.01.00.60.71.0
Cash from operations  -19.6-19.4-17.4-17.9-14.4-14.3-14.3-11.1
   
Capital expenditures  0.20.20.2-0.30.00.00.00.0
Purchases of short-term investments  2.0-0.920.7-20.7    
Other cash from investing  -21.5-21.1-36.90.1    
Cash from investing  -19.3-21.8-16.0-21.00.00.00.00.0
   
Issuance of common stock, net  8.58.6     55.9
Option exercises       0.1 0.1
Other cash from financing       0.3 0.1
Cash from financing  8.58.6-0.2-0.2-0.241.341.156.0
   
Free cash flow  -19.4-19.2-17.2-18.2-14.4-14.3-14.3-11.1
        Per share (diluted)  ($0.93)($0.94)($0.86)($1.00)($0.79)($0.71)($0.87)($0.80)
   
Cash paid for interest       0.00.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy